Filing metadata

Accession number
0001415889-24-011064
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Apr 17, 2024
Reporting period
Apr 15, 2024
Description
Insider transaction

Explore SEC Filings Hub